ConvaTec Group PLC (LSE:CTEC) - Share price - Overview

Stock Report

ConvaTec Group PLC CTEC

Last Price
£187.00

Day Change
-3.50|-1.84%

As of 19/01/2018
17:11:52 GMT | GBP
Minimum 15 Minutes Delay.

Last Close190.50
Day Range184.55 - 189.70
Mkt Cap3.65Bil
52-Wk Range181.98 - 349.10
Yield %0.00
ISINGB00BD3VFW73
Volume14,406,574
P/E-21.68
P/S2.06
P/CF46.39

Share Price

Total Returns 19/01/2018

 Chg (%)  
More ...
ConvaTec Group PLC-10.87 
FTSE 100 TR GBP2.61
 
Financials
201420152016
More ...
Income Statement
Turnover1,053.341,080.241,250.69
Operating Profit132.96150.80114.08
Net Profit-77.26-61.13-150.24
Reported EPS-3.95-3.14-10.89
Balance Sheet
Current Assets480.49513.74619.27
Non Current Assets2,041.872,058.622,219.96
Total Assets2,522.352,572.352,843.76
Current Liabilities213.76193.77242.79
Total Liabilities2,664.532,720.801,835.23
Total Equity-142.18-148.451,008.54
Cash Flow
Operating Cash Flow278.73262.07284.84
Net Change in Cash-9.1136.0611.63
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017274.1712.06-15.50-4.222.26
2018315.6913.3610.7114.001.314.982.66
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
06/12/2017PurchaseDr. Ros Rivaz206.154,8219,938.00
04/12/2017PurchaseDr. Ros Rivaz202.494,9089,938.00
31/10/2017PurchaseFrank Schulkes195.9350,00097,967.00
30/10/2017PurchaseFrank Schulkes201.4450,000100,720.00

Company Profile

ConvaTec Group PLC is a medical products and technologies company focused on therapies for the management of chronic conditions offering wound care, ostomy care, continence and critical care, and infusion devices.

Sector

Medical Devices

Market Position

128 of 1835 Companies

Index

FTSE 250 ,FTSE 350 ,FTSE All Share

Outlook

(03/08/2017) no outlook statement

Next Event 02/03/2018

Next prelim announcement
Ratios
CompSecMkt
More ...
PER (E)14.0019.965.53
Div Yld (E)2.661.574.03
PEG (E)1.311.750.98
ROCE18.5318.35180.33
Op Mrgn9.267.77-126.27
EPS Grwth10.7120.1122.39
Dividends
PreviousLatest
More ...
Record Datet.b.c.08/09/17
Ex-Divt.b.c.07/09/17
Paidt.b.c.20/10/17
Amnt0.001.06

Broker Sentiment

Strong Buy0
Buy1
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanSir Christopher Gent
Chief Executive OfficerMr. Paul Moraviec
Chief Financial OfficerFrank Schulkes
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.